On September 16, 2021 Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, reported that senior members of the executive team will be participating at the following events (Press release, Crescendo Biologics, SEP 16, 2021, View Source [SID1234587837]). They also look forward to meeting investors to discuss the Company’s business strategy, technology, discovery platform and development programmes.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit, 23 September 2021
Presentation at 9:05 am EDT, 2:05 pm BST
SVB Leerink Biopharma Private Company Connect, 27-29 October 2021
If you would like to meet the team at these events, please contact the Company via email at [email protected].
Please refer to the conference websites for further information and any updated schedules.